Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer

  • M. Crul
  • , N.E. Schoemaker
  • , D. Pluim
  • , M. Maliepaard
  • , R.W. Underberg
  • , M. Schot
  • , R.W. Sparidans
  • , P. Baas
  • , J.H. Beijnen
  • , N. van Zandwijk
  • , J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3526-3533
Number of pages8
JournalClinical Cancer Research
Volume9
Publication statusPublished - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Genetics
  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Farmacie(FARM)
  • Biochemistry
  • Biomedische technologie en medicijnen
  • Analytical chemistry

Cite this